Cargando…
The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study
BACKGROUND: In patients with stage II colorectal cancer (CRC) the number of surgically retrieved lymph nodes (LNs) is associated with prognosis, resulting in a minimum of 10–12 retrieved LNs being recommended for this stage. Current guidelines do not provide a recommendation regarding LN yield in T1...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512847/ https://www.ncbi.nlm.nih.gov/pubmed/28705200 http://dx.doi.org/10.1186/s12916-017-0892-7 |
_version_ | 1783250542002176000 |
---|---|
author | Backes, Yara Elias, Sjoerd G. Bhoelan, Bibie S. Groen, John N. van Bergeijk, Jeroen Seerden, Tom C. J. Pullens, Hendrikus J. M. Spanier, Bernhard W. M. Geesing, Joost M. J. Kessels, Koen Kerkhof, Marjon Siersema, Peter D. Cappel, Wouter H. de Vos tot Nederveen van Lelyveld, Niels Wolfhagen, Frank H. J. ter Borg, Frank Offerhaus, G. Johan A. Lacle, Miangela M. Moons, Leon M. G. |
author_facet | Backes, Yara Elias, Sjoerd G. Bhoelan, Bibie S. Groen, John N. van Bergeijk, Jeroen Seerden, Tom C. J. Pullens, Hendrikus J. M. Spanier, Bernhard W. M. Geesing, Joost M. J. Kessels, Koen Kerkhof, Marjon Siersema, Peter D. Cappel, Wouter H. de Vos tot Nederveen van Lelyveld, Niels Wolfhagen, Frank H. J. ter Borg, Frank Offerhaus, G. Johan A. Lacle, Miangela M. Moons, Leon M. G. |
author_sort | Backes, Yara |
collection | PubMed |
description | BACKGROUND: In patients with stage II colorectal cancer (CRC) the number of surgically retrieved lymph nodes (LNs) is associated with prognosis, resulting in a minimum of 10–12 retrieved LNs being recommended for this stage. Current guidelines do not provide a recommendation regarding LN yield in T1 CRC. Studies evaluating LN yield in T1 CRC suggest that such high LN yields are not feasible in this early stage, and a lower LN yield might be appropriate. We aimed to validate the cut-off of 10 retrieved LNs on risk for recurrent cancer and detection of LN metastasis (LNM) in T1 CRC, and explored whether this number is feasible in clinical practice. METHODS: Patients diagnosed with T1 CRC and treated with surgical resection between 2000 and 2014 in thirteen participating hospitals were selected from the Netherlands Cancer Registry. Medical records were reviewed to collect additional information. The association between LN yield and recurrence and LNM respectively were analyzed using 10 LNs as cut-off. Propensity score analysis using inverse probability weighting (IPW) was performed to adjust for clinical and histological confounding factors (i.e., age, sex, tumor location, size and morphology, presence of LNM, lymphovascular invasion, depth of submucosal invasion, and grade of differentiation). RESULTS: In total, 1017 patients with a median follow-up time of 49.0 months (IQR 19.6–81.5) were included. Four-hundred five patients (39.8%) had a LN yield ≥ 10. Forty-one patients (4.0%) developed recurrence. LN yield ≥ 10 was independently associated with a decreased risk for recurrence (IPW-adjusted HR 0.20; 95% CI 0.06–0.67; P = 0.009). LNM were detected in 84 patients (8.3%). LN yield ≥ 10 was independently associated with increased detection of LNM (IPW-adjusted OR 2.27; 95% CI 1.39–3.69; P = 0.001). CONCLUSIONS: In this retrospective observational study, retrieving < 10 LNs was associated with an increased risk of CRC recurrence, advocating the importance to perform an appropriate oncologic resection of the draining LNs and diligent LN search when patients with T1 CRC at high-risk for LNM are referred for surgical resection. Given that both gastroenterologists, surgeons and pathologists will encounter T1 CRCs with increasing frequency due to the introduction of national screening programs, awareness on the consequences of an inadequate LN retrieval is of utmost importance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0892-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5512847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55128472017-07-19 The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study Backes, Yara Elias, Sjoerd G. Bhoelan, Bibie S. Groen, John N. van Bergeijk, Jeroen Seerden, Tom C. J. Pullens, Hendrikus J. M. Spanier, Bernhard W. M. Geesing, Joost M. J. Kessels, Koen Kerkhof, Marjon Siersema, Peter D. Cappel, Wouter H. de Vos tot Nederveen van Lelyveld, Niels Wolfhagen, Frank H. J. ter Borg, Frank Offerhaus, G. Johan A. Lacle, Miangela M. Moons, Leon M. G. BMC Med Research Article BACKGROUND: In patients with stage II colorectal cancer (CRC) the number of surgically retrieved lymph nodes (LNs) is associated with prognosis, resulting in a minimum of 10–12 retrieved LNs being recommended for this stage. Current guidelines do not provide a recommendation regarding LN yield in T1 CRC. Studies evaluating LN yield in T1 CRC suggest that such high LN yields are not feasible in this early stage, and a lower LN yield might be appropriate. We aimed to validate the cut-off of 10 retrieved LNs on risk for recurrent cancer and detection of LN metastasis (LNM) in T1 CRC, and explored whether this number is feasible in clinical practice. METHODS: Patients diagnosed with T1 CRC and treated with surgical resection between 2000 and 2014 in thirteen participating hospitals were selected from the Netherlands Cancer Registry. Medical records were reviewed to collect additional information. The association between LN yield and recurrence and LNM respectively were analyzed using 10 LNs as cut-off. Propensity score analysis using inverse probability weighting (IPW) was performed to adjust for clinical and histological confounding factors (i.e., age, sex, tumor location, size and morphology, presence of LNM, lymphovascular invasion, depth of submucosal invasion, and grade of differentiation). RESULTS: In total, 1017 patients with a median follow-up time of 49.0 months (IQR 19.6–81.5) were included. Four-hundred five patients (39.8%) had a LN yield ≥ 10. Forty-one patients (4.0%) developed recurrence. LN yield ≥ 10 was independently associated with a decreased risk for recurrence (IPW-adjusted HR 0.20; 95% CI 0.06–0.67; P = 0.009). LNM were detected in 84 patients (8.3%). LN yield ≥ 10 was independently associated with increased detection of LNM (IPW-adjusted OR 2.27; 95% CI 1.39–3.69; P = 0.001). CONCLUSIONS: In this retrospective observational study, retrieving < 10 LNs was associated with an increased risk of CRC recurrence, advocating the importance to perform an appropriate oncologic resection of the draining LNs and diligent LN search when patients with T1 CRC at high-risk for LNM are referred for surgical resection. Given that both gastroenterologists, surgeons and pathologists will encounter T1 CRCs with increasing frequency due to the introduction of national screening programs, awareness on the consequences of an inadequate LN retrieval is of utmost importance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0892-7) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-14 /pmc/articles/PMC5512847/ /pubmed/28705200 http://dx.doi.org/10.1186/s12916-017-0892-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Backes, Yara Elias, Sjoerd G. Bhoelan, Bibie S. Groen, John N. van Bergeijk, Jeroen Seerden, Tom C. J. Pullens, Hendrikus J. M. Spanier, Bernhard W. M. Geesing, Joost M. J. Kessels, Koen Kerkhof, Marjon Siersema, Peter D. Cappel, Wouter H. de Vos tot Nederveen van Lelyveld, Niels Wolfhagen, Frank H. J. ter Borg, Frank Offerhaus, G. Johan A. Lacle, Miangela M. Moons, Leon M. G. The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title | The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title_full | The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title_fullStr | The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title_full_unstemmed | The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title_short | The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
title_sort | prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512847/ https://www.ncbi.nlm.nih.gov/pubmed/28705200 http://dx.doi.org/10.1186/s12916-017-0892-7 |
work_keys_str_mv | AT backesyara theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT eliassjoerdg theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT bhoelanbibies theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT groenjohnn theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT vanbergeijkjeroen theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT seerdentomcj theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT pullenshendrikusjm theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT spanierbernhardwm theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT geesingjoostmj theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT kesselskoen theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT kerkhofmarjon theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT siersemapeterd theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT cappelwouterhdevostotnederveen theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT vanlelyveldniels theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT wolfhagenfrankhj theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT terborgfrank theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT offerhausgjohana theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT laclemiangelam theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT moonsleonmg theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT theprognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT backesyara prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT eliassjoerdg prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT bhoelanbibies prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT groenjohnn prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT vanbergeijkjeroen prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT seerdentomcj prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT pullenshendrikusjm prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT spanierbernhardwm prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT geesingjoostmj prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT kesselskoen prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT kerkhofmarjon prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT siersemapeterd prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT cappelwouterhdevostotnederveen prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT vanlelyveldniels prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT wolfhagenfrankhj prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT terborgfrank prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT offerhausgjohana prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT laclemiangelam prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT moonsleonmg prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy AT prognosticvalueoflymphnodeyieldintheearlieststageofcolorectalcanceramulticentercohortstudy |